“The current regulatory framework requires not only a best-in-class product but a methodical approach to continuously improve quality at all levels,”
New York, NY (PRWEB)
May 26, 2017
Establishment Labs, a global medical device company focused on aesthetic technologies with a strong emphasis on product development and innovation, announced today the expansion of its leadership team with the addition of Alberto Quesada as Vice President of Quality Assurance & Regulatory Affairs.
“We are pleased to add a senior executive with Alberto’s deep expertise during this exciting stage of our growth. His background and track record of achievement within high-profile healthcare companies, such as Boston Scientific and Allergan, will add great value as we expand,” said Juan José Chacón-Quirós, CEO and founder of Establishment Labs.
“Alberto’s drive for organizational excellence and standard of quality aligns perfectly with our goal of becoming a global leader in aesthetic and reconstructive devices technology, while improving patient safety through product innovation.”
Alberto Quesada brings more than two decades of experience in quality assurance, quality control, and regulatory affairs to Establishment Labs. He will lead all activities related to the design, manufacture and distribution of quality products with the highest industry standard, as well as compliance with the company’s Quality Management System and applicable regulations. In addition, Mr. Quesada will lead all regulatory aspects of the business to support appropriate and timely introduction of products as well as a continuous state of compliance with markets’ regulatory requirements.
“The current regulatory framework requires not only a best-in-class product but a methodical approach to continuously…